China Shenghuo Reports Full Year 2007 Financi...(ty of Wei Dingkang Soft Capsules. Wei Di...),Health

Date:4/1/2008

ty of Wei Dingkang Soft Capsules. Wei Dingkang Soft Capsules use traditional Chinese medicine techniques to treat peptic ulcer disease by inhibiting helicobacter pylori growth, relieving stomach muscle spasms and reducing inflammation of the intestinal lining. The product is a National Type II innovative drug and has been designated as a Major Science and Technology Project in Yunnan Province.

"We are excited to enter late-stage development of Wei Dingkang Soft Capsules, one of the most significant new drugs in our pipeline," said Mr. Lan. "With our Good Manufacturing Practice-approved manufacturing and research and development capabilities, we look forward to leading the TCM industry by utilizing the abundant supply of Chinese herbs and introducing advanced techniques for extracting and combining key ingredients from these plants."

Business Outlook

"In 2008, we will further penetrate our target markets and strengthen relationships with our existing, well-respected distributors. As the Chinese government has enhanced its national medical health program, which increases the coverage of rural residents, we are confident that demand for our existing pharmaceutical products and those in the pipeline will benefit from expanded coverage, which will in turn increase access to our products," Mr. Lan said.

For the 2008 fiscal year, management expects revenues of between $27.0 million and $30.0 million and net income of between $5.0 million and $6.5 million.

Conference Call

The Company will host a conference call at 8:00 a.m. EDT on Wednesday, April 2, 2008, to discuss its financial results for the fiscal year ended December 31, 2007. To participate in the event by telephone, please dial (800) 638-4930 five to 10 minutes prior to the start time (to allow time for registration) and reference passcode 28825392. International callers should dial (617) 614-3944. The conference call will be broadcast live over the Internet and can be acces
'/>"/>

SOURCE China Shenghuo Pharmaceutical Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine news :

1. China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results
2. China Medicine Corporation to Present at Brean Murray Carret & Co. Mainland China Investor Tour
3. China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results
4. China Yingxia International Announces Soybean Milk Production Lines Acquisition
5. Cells from the Research Institute of the MUHC on the road to China
6. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
7. China Yingxia International Announces 2007 Fourth Quarter and Full Year Financial Results Conference Call
8. China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
9. China RuiTai International Holdings Retains CCG Elite for Investor Relations Services
10. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
11. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China